Longitudinal associations of serum MCP-1 with cognitive decline and psychological stress in biomarker-confirmed Alzheimer's disease: A pilot study
Introduction Monocyte chemoattractant protein-1 (MCP-1; also known as CCL2) is a chemokine implicated in neuroinflammatory pathways that may contribute to cognitive decline in Alzheimer's disease (AD). Elevated MCP-1 is associated with glial activation, blood-brain barrier dysfunction, and immune-cell recruitment. This...